BRWA
BSX icon

B. Riley Wealth Advisors’s Boston Scientific BSX Stock Holding History

B. Riley Wealth Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$368K Sell
8,467
-822
-9% -$44.6K 0.02% 557
2026
Q1 		$585K Sell
9,289
-4,072
-30% -$326K 0.04% 407
2025
Q4 		$1.27M Buy
13,361
+1,283
+11% +$126K 0.06% 300
2025
Q3 		$1.18M Buy
12,078
+146
+1% +$15.1K 0.05% 305
2025
Q2 		$1.28M Buy
+11,932
New +$1.21M 0.06% 294
2024
Q4 		$968K Sell
10,838
-4,715
-30% -$415K 0.03% 459
2024
Q3 		$1.3M Buy
15,553
+4,136
+36% +$326K 0.04% 432
2024
Q2 		$879K Sell
11,417
-4,853
-30% -$355K 0.02% 582
2024
Q1 		$859K Buy
16,270
+5,564
+52% +$358K 0.02% 577
2023
Q4 		$619K Sell
10,706
-5,564
-34% -$297K 0.02% 712
2023
Q3 		$859K Sell
16,270
-25,223
-61% -$1.32M 0.02% 577
2023
Q2 		$2.24M Buy
41,493
+29,159
+236% +$1.52M 0.05% 343
2023
Q1 		$617K Buy
12,334
+861
+8% +$40.6K 0.02% 724
2022
Q4 		$531K Buy
11,473
+1,001
+10% +$43.3K 0.01% 761
2022
Q3 		$407K Buy
10,472
+838
+9% +$33.6K 0.01% 851
2022
Q2 		$360K Buy
9,634
+214
+2% +$8.71K 0.02% 795
2022
Q1 		$418K Buy
9,420
+1,249
+15% +$54.1K 0.01% 843
2021
Q4 		$348K Sell
8,171
-189
-2% -$7.94K 0.01% 992
2021
Q3 		$362K Buy
8,360
+671
+9% +$29.7K 0.01% 944
2021
Q2 		$323K Sell
7,689
-148
-2% -$6.23K 0.01% 983
2021
Q1 		$302K Buy
+7,837
New +$297K 0.01% 999
2020
Q4 		– Sell
-11,796
Closed -$448K – 1034
2020
Q3 		$448K Buy
+11,796
New +$455K 0.02% 573
2020
Q1 		– Sell
-4,440
Closed -$202K – 803
2019
Q4 		$202K Sell
4,440
-6,766
-60% -$283K 0.02% 756
2019
Q3 		$457K Buy
11,206
+645
+6% +$27.3K 0.05% 436
2019
Q2 		$455K Buy
10,561
+3,128
+42% +$120K 0.05% 410
2019
Q1 		$286K Sell
7,433
-6,648
-47% -$254K 0.04% 519
2018
Q4 		$499K Sell
14,081
-156
-1% -$5.66K 0.07% 299
2018
Q3 		$549K Buy
+14,237
New +$497K 0.07% 325
2015
Q1 		– Sell
-1,346
Closed -$18 – 746
2014
Q4 		$18 Buy
+1,346
New +$17.2K ﹤0.01% 2595
2014
Q3 		– Sell
-2,228
Closed -$28.5K – 801
2014
Q2 		$28.5K Buy
+2,228
New +$29K 0.01% 1292

Other funds holding BSX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return

B. Riley Wealth Advisors's BSX Position: Q2 2026 in Review

B. Riley Wealth Advisors reduced its Boston Scientific (BSX) stake by 8.8% in Q2 2026, selling an estimated $44.6K and leaving 8,467 shares worth $368K. The position accounts for 0.02% of the portfolio, ranked #557.

B. Riley Wealth Advisors first reported a position in BSX in Q2 2014 and has held it in 30 quarters since. The position peaked at $2.24M in Q2 2023. 209 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • B. Riley Wealth Advisors held 8,467 shares of Boston Scientific worth $368K as of Q2 2026.
  • B. Riley Wealth Advisors sold 822 Boston Scientific shares in Q2 2026, an estimated $44.6K.
  • Boston Scientific made up 0.02% of B. Riley Wealth Advisors's portfolio in Q2 2026, its #557 holding.
  • B. Riley Wealth Advisors first reported a position in Boston Scientific in Q2 2014 and has held it in 30 quarters since.
  • B. Riley Wealth Advisors's Boston Scientific position peaked at $2.24M in Q2 2023.
  • 209 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on B. Riley Wealth Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.